mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.2 |